FindTrial
Sign In

Ethinylestradiol

DRUG6 trials

Sponsors

University Of Debrecen, Boehringer Ingelheim, Manuel Luque Ramírez, Janssen Research & Development, LLC, Janssen Pharmaceutica N.V., Belgium

Conditions

HealthyHealthy FemaleHepatitis C, ChronicHyperandrogenismMetabolic Cardiovascular SyndromeVenous Thromboembolism Risk associated with Hormonal Contraceptives

Phase 1

Drug-drug Interaction of Empagliflozin (BI 10773) and Microgynon
CompletedNCT01328184
Boehringer IngelheimHealthy
Start: 2011-04-30Updated: 2014-06-18
Drug-drug Interaction of BI 201335 and Microgynon
CompletedNCT01570244
Boehringer IngelheimHepatitis C, Chronic
Start: 2012-04-30End: 2012-08-31Updated: 2015-08-03
A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone
CompletedNCT02652650
Janssen Research & Development, LLCHealthy
Start: 2015-12-31End: 2016-06-30Updated: 2016-06-06
A Study of Milvexian in Healthy Adult Females
CompletedNCT05706753
Janssen Pharmaceutica N.V., BelgiumHealthy Female
Start: 2023-01-25End: 2023-07-20Updated: 2025-03-30

Phase 4

Evaluation of Thrombin Generation and Thrombosis Risk in Women on Hormonal Contraceptives with a Focus on Modifiable Risk Factors
Not yet recruitingCTIS2026-527084-15-00
University Of DebrecenVenous Thromboembolism Risk associated with Hormonal Contraceptives
Target: 350Updated: 2026-10-07

Unknown Phase

Phlebotomy and Polycystic Ovary Syndrome
CompletedNCT02460445
Manuel Luque RamírezHyperandrogenism, Metabolic Cardiovascular Syndrome
Start: 2015-01-31End: 2020-06-30Updated: 2022-07-27

Related Papers

Bloodletting has no effect on the blood pressure abnormalities of hyperandrogenic women taking oral contraceptives in a randomized clinical trial.
2021-11-11
Effect of the Hepatitis C Virus Protease Inhibitor Faldaprevir on the Pharmacokinetics of an Oral Contraceptive Containing Ethinylestradiol and Levonorgestrel in Healthy Female Volunteers
Antimicrobial Agents and Chemotherapy2014-11-116 citations